Chemometric approaches have been increasingly viewed as precious complements to high
performance liquid chromatographic practices, since a large number of variables can be …

The need for consistency in analytical method development reinforces the dependence of
pharmaceutical product development and manufacturing on robust analytical data. The …

Drug impurity and degradation profiling mean the detection, structure elucidation and
quantitative determination of impurities and degradation products in bulk drug materials and …

Green analytical chemistry principles, as well as experimental design, are a combined
approach adopted to develop sensitive reproducible stability indicating HPLC method for …

The current studies entail systematic quality by design (QbD)-based development of a
simple, rapid, sensitive and cost-effective stability-indicating method for the estimation of …

The present research work discusses the systematic Quality by Design (QbD) enabled
development of a simple, rapid, economical, and stability-indicating high-performance liquid …

By considering the current regulatory requirement for an analytical method development, a
reversed phase high performance liquid chromatographic method for routine analysis of …

Faced to the large number of potential factors in liquid chromatography, the analyst is often
led to determine through his experience the parameters to be studied. Experimental designs …

The current studies entail systematic quality by design (QbD)-based development of simple,
precise, cost-effective and stability-indicating high-performance liquid chromatography …

Pharmaceutical regulators are worried about medication quality and stability since drug
degradation may result in harmful chemicals. Erlotinib (ERL) is a tyrosine kinase inhibitor …